4.7 Article

Epithelial Cell Adhesion Molecule (EpCAM) Expression Can Be Modulated via NFκB

Journal

BIOMEDICINES
Volume 10, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines10112985

Keywords

epithelial cell adhesion molecule; acute lymphoblastic leukemia; costunolide; cell proliferation; telomerase inhibition

Funding

  1. CUI [6-43/CPRG/CIIT/ISB/17/1052]
  2. Taif University, Taif, Saudi Arabia [TURSP-2020/269]

Ask authors/readers for more resources

This study found that the expression of EpCAM in cancer cells was inhibited by costunolide, suggesting that costunolide could be a potential therapeutic biomolecule for leukemia.
The epithelial cell adhesion molecule (EpCAM) is considered an essential proliferation signature in cancer. In the current research study, qPCR induced expression of EpCAM was noted in acute lymphoblastic leukemia (ALL) cases. Costunolide, a sesquiterpene lactone found in crepe ginger and lettuce, is a medicinal herb with anticancer properties. Expression of EpCAM and its downstream target genes (Myc and TERT) wasdownregulated upon treatment with costunolide in Jurkat cells. A significant change in the telomere length of Jurkat cells was not noted at 72 h of costunolide treatment. An in silico study revealed hydrophobic interactions between EpCAM extracellular domain and Myc bHLH with costunolide. Reduced expression of NF kappa B, a transcription factor of EpCAM, Myc, and TERT in costunolide-treated Jurkat cells, suggested that costunolide inhibits gene expression by targeting NF kappa B and its downstream targets. Overall, the study proposes that costunolide could be a promising therapeutic biomolecule for leukemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available